Resumen
Objetivo: Resumir las principales enfermedades benignas de la mama, diagnóstico y tratamiento. Revisión bibliográfica: Las enfermedades mamarias benignas constituyen un amplio espectro de cambios anatómicos o funcionales en la glándula mamaria, siendo el 80 por ciento de las lesiones mamarias benignas. Las enfermedades mamarias benignas pueden ser palpables o estar presentes sólo en un examen por imágenes. El ginecólogo debe estar atento y conocer el diagrama de flujo para investigar los cambios en la mama. Se deben investigar lesiones cutáneas, masas tumorales o secreción del pezón y se debe excluir la posibilidad de neoplasia. Consideraciones finales: La investigación sobre el descubrimiento de cambios mamarios se individualizará según la edad de la paciente, factores de riesgo, resultados clínicos y radiológicos. Una vez descartada la posibilidad de malignidad, se debe dar el foco al tratamiento de la enfermedad benigna y orientar en el seguimiento de los hallazgos, siendo fundamental que todo profesional involucrado en la atención de pacientes con signos o síntomas mamarios conozca el flujo adecuado de investigación y seguimiento de estas lesiones.
Referencias
AGOCHUKWU NB e WONG L. Diabetic Mastopathy. Annals of Plastic Surgery, 2017; 78(4): 471–475.
BAGNOLI Fl. Mastologia: do diagnóstico ao tratamento. Goiânia: Conexão Propaganda e Editora, 2017. 277-285 p.
Breast biopsy. 2023. In: UpToDate. Disponível em: https://www.uptodate.com/contents/breast-biopsy. Acesso em: 26 jan 2024.
Breast cysts: Clinical manifestations, diagnosis, and management. 2022. In: UpToDate. Disponível em: https://medilib.ir/uptodate/show/799. Acesso em: 26 jan 2024.
Breast masses in children and adolescents. 2022. In: UpToDate. Wolters Kluwer Health. Disponível em: https://www.uptodate.com/contents/breast-masses-in-children-and-adolescents. Acesso em: 26 jan 2024.
Clinical manifestations and diagnosis of sarcoidosis. 2023. In: UpToDate. Disponível em: https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-sarcoidosis. Acesso em: 26 jan 2024.
Clinical manifestations, differential diagnosis, and clinical evaluation of a palpable breast mass. In: UpToDate, 2021. Disponível em: https://www.uptodate.com/contents/clinical-manifestations-differential-diagnosis-and-clinicalevaluation-of-a-palpable-breast-mass. Acesso em: 03 abr 2024.
Consensus Guideline on Concordance Assessment of Image-Guided Breast Biopsies and Management of Borderline or High-Risk Lesions. 2016. In: The American Society of Breast Surgeons. Disponível em: https://www.breastsurgeons.org/docs/statements/Consensus-Guideline-on-Concordance-Assessment-of-Image-Guided-Breast-Biopsies.pdf. Acesso em: 26 jan 2024.
COSTA L. S. et al. Fatores de risco relacionados ao câncer de mama e a importância da detecção precoce para a saúde da mulher. Revista Eletrônica Acervo Científico. 2021; 31, e8174.
EFARED B. et al. Tubular Adenoma of the Breast: A Clinicopathologic Study of a Series of 9 Cases. Clinical Medicine Insights. Pathology, 2018; 11, p. 1179555718757499.
FAINA NAKHLIS et al. The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034). Annals of Surgical Oncology, 2020; 28(5): 2573–2578.
FERNANDES CE; SÁ MFS. Tratado de ginecologia Febrasgo. 2. ed. Rio de Janeiro: Elsevier, 2019. 998 p.
Girianelli VR, Gamarra CJ, Azevedo SG. Disparidades na mortalidade por câncer cervical e de mama no Brasil. Rev. Saúde Pública. 2014; 48 (3): 459-467.
GUZIK, P, et al. Diabetic Mastopathy. Review of Diagnostic Methods and Therapeutic Options. International Journal of Environmental Research and Public Health, 2021; 19(1): 448–448.
HINKLE e CHEEVER. Kerry H. Brunner & Suddarth: Tratado de Enfermagem Médico--Cirúrgica. 13. ed. Rio de Janeiro, RJ: Guanabara Koogan, 2017.
HUDSON-PHILLIPS S, et al. Fibroadenoma: a guide for junior clinicians. British journal of hospital medicine, 2022; 83(10): 1–9.
INSTITUTO NACIONAL DE CÂNCER. Programa Saber Saúde. Rio de Janeiro: INCA, 2021. Disponível em: https://www.inca.gov.br/programa-nacional-de-controle-do-tabagismo/programa-saber-saude. Acesso em: 02 abr 2024.
LONDON SJ, et al. A prospective study of benign breast disease and the risk of breast câncer, JAMA, 1992, 267(7):941.
MAHMOUD, W. et al. Giant mammary hamartoma in a middle aged female. Case report and review of literature of the last 15 years. International Journal of Surgery Case Reports, 2021, 78:145–150.
NASCIMENTO MA, et al. Câncer de Mama: Fatores de Risco e Prevenção. Estudos Avançados sobre Saúde e Natureza, 2024; 18.
NASSER, H. A. et al. Breast manifestations of type I diabetes mellitus. The Breast Journal, 2020. 26(10):2079–2080.
Nonlactational mastitis in adults. 2024. In: UpToDate. Disponível em: https://www.uptodate.com/contents/nonlactational-mastitis-in-adults. Acesso em: 26 jan 2024.
PLEASANT, V. Benign Breast Disease. Clinical Obstetrics and Gynecology, 2022; 65(3):448.
SABATE, J. M. et al. Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics, 2007; 27(1):101.
ORR B; KELLEY JL. Benign Breast Diseases: Evaluation and Management. Clinical Obstetrics & Gynecology, 2016; 59(4): 710–726.
Overview of benign breast diseases, 2021. In: UpToDate. Disponível em: https://medilib.ir/uptodate/show/806. Acesso em: 26 jan 2024.
SALZMAN B et al. Common Breast Problems. American Family Physician, 2019; 99(8): 505–514.
SCHNITT SJ e COLLINS LC. Pathology of benign breast disorders. Lippincott, 2010. 69.
SENGUPTA S. et al. Preoperative diagnosis of tubular adenoma of breast - 10 years of experience. North American Journal of Medical Sciences, 2014; 6 (5):219.
SIEGEL, Marilyn J.; CHUNG, Ellen. Breast masses in children and adolescents. Applied Radiology; 2017, 12-17.
STACHS, A. et al. Benign breast disease in women. Deutsches Aerzteblatt Online, 2019; 116, 33-34.
VISSCHER, D. W. et al. Sclerosing adenosis and risk of breast cancer. Breast Cancer Research and Treatment, 2014; 144(1), 205–212.
